Last reviewed · How we verify
Plasma Sampling — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Plasma Sampling (Plasma Sampling) — Eisai Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Plasma Sampling TARGET | Plasma Sampling | Eisai Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Plasma Sampling CI watch — RSS
- Plasma Sampling CI watch — Atom
- Plasma Sampling CI watch — JSON
- Plasma Sampling alone — RSS
Cite this brief
Drug Landscape (2026). Plasma Sampling — Competitive Intelligence Brief. https://druglandscape.com/ci/plasma-sampling. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab